Prevalence of psychosis in South Asia: A systematic review and meta-analysis.

Schizophr ResJul 21, 2026 (epub)
Clinical ResearchPsychiatry

Roopal Desai, Zahid Abdur-Rahman, Ashley Boscoe et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis assessed the prevalence of psychosis in South Asia, analyzing data from 31 studies across five countries. The pooled point prevalence among community-dwelling adults was found to be 0.85%, while the lifetime prevalence was 1.40%. Notably, clinical samples showed a higher prevalence of 11.44%.

Key findings

  • Pooled point prevalence of psychosis in community-dwelling adults was 0.85%.
  • Lifetime prevalence of psychosis was 1.40% across South Asia.
  • Clinical samples exhibited a significantly higher prevalence of 11.44%.
  • Inter-country differences were noted, with Nepal showing the highest prevalence at 2.90%.

Why it matters

Understanding the prevalence of psychosis in South Asia is crucial for health service planning and policy-making, especially given the region's significant population and the existing treatment gap for mental health disorders.

Source

Published in Schizophr Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.